Merck partner NGM biopharmaceuticals’ eye drug unsuccessful in Phase 2 clinical trials

October 31, 2022

AstraZeneca Looking For Another Liver Cancer Green Light For Imfinzi

November 13, 2023

Merck broadens the supply of COVID 19 pills in China

October 5, 2022

Must Read

How Pharma Companies Are Adapting to Market Disruption

April 14, 2026

How Is AI Transforming Market Access and Commercial Decision-Making?

April 14, 2026

How Are Biotech Firms Building Resilient Innovation Pipelines?

April 14, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028

IDEAYA and Servier Report Phase 2/3 Trial Success for Darovasertib Combination in Uveal Melanoma

Revolution Meets Key Survival Goals With RAS Inhibitor In Important Trial

Tepezza Sales Dip Slightly as Subcutaneous Formulation Shows Late-Stage Efficacy

Sanofi’s Bispecific Stumbles in Eczema but Delivers Dual Wins in Respiratory Trials

Regeneron Partners with Telix in Radiopharmaceutical Collaboration Covering Up to Eight Cancer Programs

OrbiMed Announces $137M Series B Financing For Sidewinder

Roche Commits $20 Million Upfront and Over $1 Billion in Milestones in C4 Therapeutics DAC Partnership

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

How Pharma Companies Are Adapting to Market Disruption

How Is AI Transforming Market Access and Commercial Decision-Making?

How Are Biotech Firms Building Resilient Innovation Pipelines?

The Rise of Value-Based Pricing in Life Sciences

Tag: Roche

Roche Shares Fall After Phase 3 Trial of Breast Cancer Drug Giredestrant Misses Primary Endpoint

Editor Picks

Merck partner NGM biopharmaceuticals’ eye drug unsuccessful in Phase 2 clinical trials

AstraZeneca Looking For Another Liver Cancer Green Light For Imfinzi

Merck broadens the supply of COVID 19 pills in China

Must Read

How Pharma Companies Are Adapting to Market Disruption

How Is AI Transforming Market Access and Commercial Decision-Making?

How Are Biotech Firms Building Resilient Innovation Pipelines?

Hot Topics

About Us

Follow Us